Iradimed Corp. (IRMD) – Globe Newswire
-
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
-
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
-
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
-
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
-
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
-
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
-
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
-
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
-
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
-
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
-
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
-
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
-
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
-
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
-
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
-
IRADIMED CORPORATION Issues Urgent Medical Device Correction
-
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend
-
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
-
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
-
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
-
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
-
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
-
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
-
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
-
UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
-
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
-
IRADIMED Names John F. Glenn Chief Financial Officer
-
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
-
IRADIMED CORPORATION Announces Executive Transition
-
IRADIMED CORPORATION to Hold 2022 First Quarter Financial Results Conference Call on April 29th
-
IRADIMED Announces Special $1.00 Per Share Cash Dividend
-
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
-
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
-
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
-
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
-
IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
-
IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th
-
IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
-
IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th
-
IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results
-
IRADIMED CORPORATION to Hold 2020 Fourth Quarter Financial Results Conference Call on February 4th
-
IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results
-
IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th
-
IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results
-
IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th
-
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer
-
IRADIMED CORPORATION Announces Issuance of U.S. Patent
-
IRADIMED CORPORATION Announces First Quarter 2020 Financial Results
-
IRADIMED CORPORATION to Hold 2020 First Quarter Financial Results Conference Call on April 30th
Back to IRMD Stock Lookup